Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Telehealth giants pairing obesity drugs with weight-loss programs to prevent overreliance on prescriptions
By
Aaron Dorman
Aug 23, 2023
Telehealth companies could offer, or even require, virtual fitness program pairing with obesity drugs, as new procedures are developed.
Med-management software company releases new tool for nursing facilities to meet new need for CMS compliance
By
Aaron Dorman
Sep 20, 2023
To meet new CMS rules for nursing homes, one company is releasing a new service that focuses on ensuring a patient’s medication listings are up-to-date.
Diabetes drug maker sues over compounded versions of Mounjaro
Sep 20, 2023
The lawsuits are meant to stop the other companies from “the unlawful marketing and sale of non-FDA approved compounded products.”
AI helps prevent prescription dosing errors
By
Christine Birkner
Jun 02, 2023
Software company DrFirst developed an AI-powered tool to streamline medication refill and renewal requests.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
DEA extends telemedicine for prescribing controlled meds as pandemic measures end
May 10, 2023
The extension through Nov. 11 gives the DEA and HHS a chance to consider revisions and public comments regarding proposals offered March 1.
US medical drug shortages reach record high
Apr 15, 2024
Americans are facing more shortages of the drugs they need for medical care than ever before, a national pharmacy database shows.
Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
Antipsychotic prescribing increases in assisted living during pandemic: study
By
Kimberly Bonvissuto
Apr 11, 2022
The prescribing of antipsychotic medications in assisted living communities and nursing homes has increased by 1.5% since the beginning of the COVID-19 pandemic, according to a recent study.